• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2020 o Market outlook: Forecast for 2020 - 2025 • Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Composition o Market segments o Comparison by Composition o Mono vaccines - Market size and forecast 2020-2025 o Combination vaccines - Market size and forecast 2020-2025 o Market opportunity by Composition • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2020-2025 o Europe - Market size and forecast 2020-2025 o Asia - Market size and forecast 2020-2025 o ROW - Market size and forecast 2020-2025 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Baxter International Inc. o Bio-Med Pvt. Ltd. o GlaxoSmithKline Plc o Incepta Vaccine Ltd. o Merck and Co. Inc. o Novartis AG o Pfizer Inc. o Sanofi SA o Serum Institute of India Pvt. Ltd. o Walvax Biotechnology Co. Ltd. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits Exhibits1: Key Finding 1 Exhibits2: Key Finding 2 Exhibits3: Key Finding 3 Exhibits4: Key Finding 5 Exhibits5: Key Finding 6 Exhibits6: Key Finding 7 Exhibits7: Key Finding 8 Exhibits8: Parent market Exhibits9: Market characteristics Exhibits10: Offerings of vendors included in the market definition Exhibits11: Market segments Exhibits12: Global - Market size and forecast 2020 - 2025 ($ million) Exhibits13: Global market: Year-over-year growth 2020 - 2025 (%) Exhibits14: Five forces analysis 2020 & 2025 Exhibits15: Bargaining power of buyers Exhibits16: Bargaining power of suppliers Exhibits17: Threat of new entrants Exhibits18: Threat of substitutes Exhibits19: Threat of rivalry Exhibits20: Market condition - Five forces 2020 Exhibits21: Composition - Market share 2020-2025 (%) Exhibits22: Comparison by Composition Exhibits23: Mono vaccines - Market size and forecast 2020-2025 ($ million) Exhibits24: Mono vaccines - Year-over-year growth 2020-2025 (%) Exhibits25: Combination vaccines - Market size and forecast 2020-2025 ($ million) Exhibits26: Combination vaccines - Year-over-year growth 2020-2025 (%) Exhibits27: Market opportunity by Composition Exhibits28: Customer landscape Exhibits29: Market share By Geographical Landscape 2020-2025 (%) Exhibits30: Geographic comparison Exhibits31: North America - Market size and forecast 2020-2025 ($ million) Exhibits32: North America - Year-over-year growth 2020-2025 (%) Exhibits33: Europe - Market size and forecast 2020-2025 ($ million) Exhibits34: Europe - Year-over-year growth 2020-2025 (%) Exhibits35: Asia - Market size and forecast 2020-2025 ($ million) Exhibits36: Asia - Year-over-year growth 2020-2025 (%) Exhibits37: ROW - Market size and forecast 2020-2025 ($ million) Exhibits38: ROW - Year-over-year growth 2020-2025 (%) Exhibits39: Key leading countries Exhibits40: Market opportunity By Geographical Landscape ($ million) Exhibits41: Impact of drivers and challenges Exhibits42: Vendor landscape Exhibits43: Landscape disruption Exhibits44: Industry risks Exhibits45: Vendors covered Exhibits46: Market positioning of vendors Exhibits47: Baxter International Inc. - Overview Exhibits48: Baxter International Inc. - Business segments Exhibits49: Baxter International Inc. - Key offerings Exhibits50: Baxter International Inc. - Key customers Exhibits51: Baxter International Inc. - Segment focus Exhibits52: Bio-Med Pvt. Ltd. - Overview Exhibits53: Bio-Med Pvt. Ltd. - Product and service Exhibits54: Bio-Med Pvt. Ltd. - Key offerings Exhibits55: Bio-Med Pvt. Ltd. - Key customers Exhibits56: Bio-Med Pvt. Ltd. - Segment focus Exhibits57: GlaxoSmithKline Plc - Overview Exhibits58: GlaxoSmithKline Plc - Business segments Exhibits59: GlaxoSmithKline Plc - Key offerings Exhibits60: GlaxoSmithKline Plc - Key customers Exhibits61: GlaxoSmithKline Plc - Segment focus Exhibits62: Incepta Vaccine Ltd. - Overview Exhibits63: Incepta Vaccine Ltd. - Product and service Exhibits64: Incepta Vaccine Ltd. - Key offerings Exhibits65: Incepta Vaccine Ltd. - Key customers Exhibits66: Incepta Vaccine Ltd. - Segment focus Exhibits67: Merck and Co. Inc. - Overview Exhibits68: Merck and Co. Inc. - Business segments Exhibits69: Merck and Co. Inc. - Key offerings Exhibits70: Merck and Co. Inc. - Key customers Exhibits71: Merck and Co. Inc. - Segment focus Exhibits72: Novartis AG - Overview Exhibits73: Novartis AG - Business segments Exhibits74: Novartis AG - Key offerings Exhibits75: Novartis AG - Key customers Exhibits76: Novartis AG - Segment focus Exhibits77: Pfizer Inc. - Overview Exhibits78: Pfizer Inc. - Business segments Exhibits79: Pfizer Inc. - Key offerings Exhibits80: Pfizer Inc. - Key customers Exhibits81: Pfizer Inc. - Segment focus Exhibits82: Sanofi SA - Overview Exhibits83: Sanofi SA - Business segments Exhibits84: Sanofi SA - Key offerings Exhibits85: Sanofi SA - Key customers Exhibits86: Sanofi SA - Segment focus Exhibits87: Serum Institute of India Pvt. Ltd. - Overview Exhibits88: Serum Institute of India Pvt. Ltd. - Product and service Exhibits89: Serum Institute of India Pvt. Ltd. - Key offerings Exhibits90: Serum Institute of India Pvt. Ltd. - Key customers Exhibits91: Serum Institute of India Pvt. Ltd. - Segment focus Exhibits92: Walvax Biotechnology Co. Ltd.- Overview Exhibits93: Walvax Biotechnology Co. Ltd.- Product and service Exhibits94: Walvax Biotechnology Co. Ltd.- Key offerings Exhibits95: Walvax Biotechnology Co. Ltd.- Key customers Exhibits96: Walvax Biotechnology Co. Ltd.- Segment focus Exhibits97: Currency conversion rates for US$ Exhibits98: Research Methodology Exhibits99: Validation techniques employed for market sizing Exhibits100: Information sources Exhibits101: List of abbreviations

Baxter International Inc., Bio-Med Pvt. Ltd., GlaxoSmithKline Plc, Incepta Vaccine Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co. Ltd.